(Press-News.org) June 5, 2024 (Cambridge, MA) - Cirrus Therapeutics, the University of Bristol, and London’s Global University Institute of Ophthalmology have discovered a revolutionary treatment for age-related macular degeneration (AMD), the leading cause of vision loss among older adults.
Featured on the cover of the journal Science Translational Medicine, this breakthrough research reveals that boosting a specific protein, IRAK-M, in retinal cells could offer a new and highly effective therapy for AMD.
AMD can severely impact a person’s vision. Patients suffering from AMD often start with blurred vision or seeing a black dot in their central vision, which can ultimately expand to the point where there is no useful central vision. Currently, AMD affects approximately 200 million people worldwide, a number projected to rise to 288 million by 2040 with graying populations. The exact cause of AMD is complex and thought to involve a combination of aging, environmental, and lifestyle factors.
The team found that augmenting IRAK-M levels in retinal cells can significantly protect against retinal degeneration. “This discovery represents the first pathway-agnostic approach toward AMD, offering a comprehensive treatment option for the millions of people who suffer from this debilitating condition,” said Dr. Andrew Dick, Head of the Academic Unit of Ophthalmology at the University of Bristol, Director of the UCL Institute of Ophthalmology, and co-founder and Chief Scientific Advisor of Cirrus Therapeutics.
Dr. Jian Liu, the first author and senior research scientist at the Academic Unit of Ophthalmology of the University of Bristol, added, “Since age stands as a primary risk factor for AMD, the gradual decrease of IRAK- M levels with age, which further declines in AMD, is a key way to identify the potential markers of early AMD progression and ultimately a new way of treatment.”
This discovery will build and improve upon current treatments for AMD, which are targeting single pathophysiology pathways. “Our novel approach not only addresses the multiple pathways involved in treating AMD but also offers the most compelling and evidence-based strategy available today,” said Cirrus Therapeutics co-founder and Chief Executive Officer Dr. Ying Kai Chan.
Cirrus Therapeutics recently spun out of the University of Bristol to develop therapies related to this discovery.
The research for this paper was funded by the Rosetrees Trust, Stoneygate Trust, Underwood Trust, Macular Society, Sight Research UK, Moran Eye Center at the University of Utah, Sharon Eccles Steele Center for Translation, and supported by the National Institute for Health and Care Research (NIHR) BRC Moorfields and UCL-Institute of Ophthalmology.
About Cirrus Therapeutics
Cirrus Therapeutics is an ocular immunology-focused company co-founded by Dr. Ying Kai Chan, former Chief Scientific Officer of Ally Therapeutics and Blavatnik Fellow at Harvard Business School, and Dr. Andrew Dick, Professor and Head of the Academic Unit of Ophthalmology at the University of Bristol and Director of UCL Institute of Ophthalmology.
Cirrus, a spin-out from the University of Bristol, is developing treatments for long-term eye diseases that can cause blindness, focusing on conditions that affect the ocular immune system.
Cirrus’ lead program is a differentiated and first-in-class approach to treating dry age-related macular degeneration (AMD), the leading cause of vision loss among older adults.
Dr. Dick, Dr. Chan, and colleagues found that increasing the protein IRAK-M in retinal cells can significantly protect against retinal degeneration. This discovery will build and improve upon current treatments for AMD, which only have the capacity to address single pathophysiology pathways.
Cirrus’ novel approach not only addresses the multiple pathways involved in treating AMD but also offers the most compelling and evidence-based strategy available today.
Cirrus Therapeutics is actively engaging with investors to raise financing to advance its therapeutics programs. Interested parties may reach out at info@cirrustx.com.
About the University of Bristol
The University is ranked within the top 10 universities in the UK and 55th in the world (QS World University Rankings 2024); it is also ranked among the top five institutions in the UK for its research, according to analysis of the Research Excellence Framework (REF) 2021; and is the 5th most targeted university by top UK employers.
The University was founded in 1876 and was granted its Royal Charter in 1909. It was the first university in England to admit women on the same basis as men.
The University is a major force in the economic, social and cultural life of Bristol and the region, but is also a significant player on the world stage. It has over 20,000 undergraduates and over 7,000 postgraduate students from more than 150 countries, and its research links span the globe.
About London’s Global University Institute of Ophthalmology
UCL Institute of Ophthalmology is world-leading for research and teaching in ophthalmology and biomedical science. The Institute delivers advanced ophthalmic research and education in partnership with Moorfields Eye Hospital.
Image (for use only with this study) can be downloaded from the following URL:
https://fluff.bris.ac.uk/fluff/u2/ficmc/24vuJNzdpZ_8UZNFGq54hgIlA/
Image Caption: IRAK-M gene therapy prevents degeneration of retinal pigment epithelium. Credit: Liu et al./Science Translational Medicine
For further information or to arrange an interview with the researchers, please contact Dr. Ying Kai Chan and Dr. Andrew Dick at info@cirrustx.com.
END
Researchers unveil pioneering approach to combat age-related vision loss
2024-06-05
ELSE PRESS RELEASES FROM THIS DATE:
MSU research: What makes a good headline?
2024-06-05
EAST LANSING, Mich. – The competition for online attention in today’s news environment is fierce. High-quality news from credible sources must compete for attention with misinformation and a rapidly increasing amount of partisan content.
How can a news organization stand out as a reputable and trustworthy outlet while driving readers to its site?
The answer is simple: literally.
According to research from Michigan State University, news readers engage more with simple writing, suggesting journalists ...
Scientists identify ‘missing piece’ required for blood stem cell self-renewal
2024-06-05
UCLA scientists have identified a protein that plays a critical role in regulating human blood stem cell self-renewal by helping them sense and interpret signals from their environment.
The study, published in Nature, brings researchers one step closer to developing methods to expand blood stem cells in a lab dish, which could make life-saving transplants of these cells more available and increase the safety of blood stem cell-based treatments, such as gene therapies.
Blood stem cells, also known as hematopoietic stem cells, have the ability to make copies of themselves via a process called ...
Father's diet before conception influences children's health
2024-06-05
Dr. Raffaele Teperino, head of the "Environmental Epigenetics" research group at Helmholtz Munich, along with his research team, has examined the impact of paternal diet on children's health – specifically, the influence of diet before conception. The researchers focused on special small RNA molecules in sperm, known as mitochondrial tRNA fragments (mt-tsRNAs, see background). These RNAs play a key role in the inheritance of health traits by regulating gene expression.
For their study, the researchers used data from the LIFE Child cohort, which includes information from over 3,000 families. The analyses showed ...
Fountain of youth for plants: E3 ligase's role in leaf longevity
2024-06-05
A new study uncovers the intricate molecular mechanisms that regulate leaf senescence in apple plants, focusing on the crucial role of the E3 ligase enzyme, MdPUB23, and its interaction with the ABI5 protein. This research provides valuable insights into how plants manage stress responses and maintain growth, offering potential applications in improving crop yield and stress resistance.
Leaf senescence is a vital phase in the life cycle of plants, impacting overall plant health and yield. Abscisic acid (ABA) ...
Drones and AI harnessed to monitor invasive stink bugs
2024-06-05
Researchers in Italy have unveiled the first successful application of commercial drones combined with artificial intelligence (AI) to monitor the invasive agricultural pest, Halyomorpha halys, commonly known as the brown marmorated stink bug. This research, published in the SCI journal Pest Management Science, marks a significant advancement in the use of unmanned aerial vehicles (UAVs) for automated monitoring of invasive species.
Halyomorpha halys is notorious for its extensive damage to orchard crops across North America and southern Europe. In Italy, this invasive pest caused an ...
Unlocking salt resistance: sea lavender's genetic secret revealed
2024-06-05
Recent research has uncovered the genetic mechanisms behind sea lavender's (Limonium bicolor) salt tolerance by studying basic helix–loop–helix (bHLH) transcription factors. Identifying 187 bHLH genes, the study highlights their roles in salt gland development and stress responses. CRISPR-Cas9 validation demonstrated specific bHLH genes' critical role in enhancing salt tolerance, paving the way for future applications in crop improvement and saline soil management.
Basic helix–loop–helix (bHLH) transcription factors are essential for various plant processes, including ...
Six UTA faculty receive prestigious CAREER grants
2024-06-05
Six faculty members from The University of Texas at Arlington received more than $3.23 million in awards as part of the National Science Foundation’s (NSF) Faculty Early Career Development Program. Called CAREER, these awards are considered the NSF’s most prestigious for early-career faculty and are given to those who have the potential to serve as academic role models in research and education.
Between 2017 and 2022, UTA received nine CAREER awards; in 2023, it received six. Vice President of research and innovation Kate C. Miller called this “a true testament to the world-class research teams we’re assembling here in Arlington.”
“CAREER ...
Brain overgrowth dictates autism severity, new research suggests
2024-06-05
Some children with autism experience profound, lifelong difficulties like developmental delay, social struggles and even the inability to speak. Others experience more mild symptoms that improve with time.
The disparity in outcomes has been a mystery to scientists, until now. A new study, published in Molecular Autism by researchers at University of California San Diego, is the first to shed light on the matter. Among its findings: The biological basis for these two subtypes of autism develops in utero.
Researchers ...
MD Anderson Research Highlights for June 5, 2024
2024-06-05
HOUSTON ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Recent developments at MD Anderson offer insights into a lower-intensity therapy combination for older patients with acute myeloid leukemia (AML), a novel T cell therapy for patients with bone marrow failure syndromes, a proof-of-concept study using MRI to detect metabolic changes inside tumors, a molecular target to overcome treatment resistance ...
New study finds many of the world’s most threatened species lack evidence of sufficient conservation efforts
2024-06-05
-With images-
A new study has revealed alarming gaps in the implementation of conservation interventions for thousands of the world's most threatened species.
The research, published in the journal Nature, shows that most terrestrial plant and animal species at risk of extinction from threats like habitat loss, over-exploitation for trade, and invasive species are not receiving the appropriate types of conservation efforts needed to protect them.
The study findings suggest that there is a serious mismatch between the ...